These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27003163)

  • 1. Effects of a Gentle, Self-Administered Stimulation of Perineal Skin for Nocturia in Elderly Women: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
    Iimura K; Watanabe N; Masunaga K; Miyazaki S; Hotta H; Kim H; Hisajima T; Takahashi H; Kasuya Y
    PLoS One; 2016; 11(3):e0151726. PubMed ID: 27003163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentle Perineal Skin Stimulation for Control of Nocturia.
    Hotta H; Watanabe N
    Anat Rec (Hoboken); 2019 Oct; 302(10):1824-1836. PubMed ID: 30980505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Effects of a Gentle, Self-Administered Stimulation of Perineal Skin for Nocturia in Elderly Women: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
    Griebling TL
    J Urol; 2016 Dec; 196(6):1709-1712. PubMed ID: 27845118
    [No Abstract]   [Full Text] [Related]  

  • 4. A gentle mechanical skin stimulation technique for inhibition of micturition contractions of the urinary bladder.
    Hotta H; Masunaga K; Miyazaki S; Watanabe N; Kasuya Y
    Auton Neurosci; 2012 Apr; 167(1-2):12-20. PubMed ID: 22154753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does successful treatment of overactive bladder improve co-morbidities in patients with nocturia?
    Chin KS; Rose GE; Ervin CF; Ong TJ; Whishaw DM; Bower WF
    Australas J Ageing; 2019 Dec; 38(4):242-248. PubMed ID: 30865375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
    Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
    Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder in Asia.
    Kuo HC; Lee KS; Na Y; Sood R; Nakaji S; Kubota Y; Kuroishi K
    Neurourol Urodyn; 2015 Sep; 34(7):685-92. PubMed ID: 25130281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentle Mechanical Skin Stimulation Inhibits Micturition Contractions via the Spinal Opioidergic System and by Decreasing Both Ascending and Descending Transmissions of the Micturition Reflex in the Spinal Cord.
    Hotta H; Watanabe N
    PLoS One; 2015; 10(8):e0135185. PubMed ID: 26252000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proof-of-concept study: mirabegron, a new therapy for overactive bladder.
    Chapple CR; Amarenco G; López Aramburu MA; Everaert K; Liehne J; Lucas M; Vik V; Ridder A; Snijder R; Yamaguchi O;
    Neurourol Urodyn; 2013 Nov; 32(8):1116-22. PubMed ID: 23424164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS).
    Delgado D; Canham L; Cotterill N; Cottrell D; Drake MJ; Inglis K; Owen D; White P
    BMC Neurol; 2017 Mar; 17(1):63. PubMed ID: 28347292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia.
    Kaplan SA; Roehrborn CG; Dmochowski R; Rovner ES; Wang JT; Guan Z
    Urology; 2006 Aug; 68(2):328-32. PubMed ID: 16904446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).
    Drake MJ; Canham L; Cotterill N; Delgado D; Homewood J; Inglis K; Johnson L; Kisanga MC; Owen D; White P; Cottrell D
    BMC Neurol; 2018 Aug; 18(1):107. PubMed ID: 30081859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the bladder: poor sleep in women with overactive bladder syndrome.
    Savoie MB; Lee KA; Subak LL; Hernandez C; Schembri M; Fung CH; Grady D; Huang AJ
    Am J Obstet Gynecol; 2020 Jun; 222(6):600.e1-600.e13. PubMed ID: 31836545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial.
    Wagg A; Khullar V; Marschall-Kehrel D; Michel MC; Oelke M; Darekar A; Bitoun CE; Weinstein D; Osterloh I
    J Am Geriatr Soc; 2013 Feb; 61(2):185-93. PubMed ID: 23350833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of novel β
    Yoshida M; Takeda M; Gotoh M; Yokoyama O; Kakizaki H; Takahashi S; Masumori N; Nagai S; Hashimoto K; Minemura K
    Int J Urol; 2019 Mar; 26(3):369-375. PubMed ID: 30557916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder.
    Ohlstein EH; von Keitz A; Michel MC
    Eur Urol; 2012 Nov; 62(5):834-40. PubMed ID: 22695239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double-blind placebo controlled trial.
    Schoendorfer N; Sharp N; Seipel T; Schauss AG; Ahuja KDK
    BMC Complement Altern Med; 2018 Jan; 18(1):42. PubMed ID: 29385990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia.
    Rackley R; Weiss JP; Rovner ES; Wang JT; Guan Z;
    Urology; 2006 Apr; 67(4):731-6; discussion 736. PubMed ID: 16618562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.